In the US, RiaSTAP (fibrinogen systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Congenital Fibrinogen Deficiency.
US matches:
- RiaSTAP
Ingredient matches for RiaSTAP
Fibrinogen, human
Fibrinogen, human is reported as an ingredient of RiaSTAP in the following countries:
- United States
International Drug Name Search
No comments:
Post a Comment